Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRM7 antisense RNA 1 (GRM7-AS1) is a long non-coding RNA gene transcribed antisense to the GRM7 gene. It does not code for protein and is classified as a regulatory RNA. Its precise biological function is currently unclear, but, by analogy with other antisense lncRNAs, it may play a role in the transcriptional or post-transcriptional regulation of GRM7 gene expression. There is no published evidence linking GRM7-AS1 to any human disease, nor is it known as a therapeutic target or biomarker. No drugs or mechanisms of action are described for modulation of GRM7-AS1 directly. It is recognized in gene annotation databases and research resources as a bona fide RNA gene.
None (no drugs or therapies target GRM7-AS1 directly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GRM7 antisense RNA 1 (GRM7-AS1).